Literature DB >> 174915

Cerebrospinal fluid concentration of cyclic AMP in cerebrovascular diseases.

E R Heikkinen, V V Myllylä, E Hokkanen, H Vapaatalo.   

Abstract

Concentration of cyclic adenosine 3',5'-monophosphate (cAMP) and activities of some enzymes were measured in cerebrospinal fluid (CSF) from 38 patients with various cerebrovascular diseases. Cerebral infarction of the carotid area (less than 14 days after the attack) revealed a significant increase in CSF cAMP level in comparison to a transient ischemic attack (TIA) and cephalagia without any pathological findings (control group). A trend towards elevated values was observed also in cerebral hemorrhage, whereas the CSF cAMP concentrations in subarachnoid hemorrhage, TIA, syncope, and cerebral infarction of at least 2 months of duration were in the range of control values. A significant rise in CSF enzyme activities was observed only in hemorrhagic disorders. Hypertensive patients with TIA showed significantly higher CSF cAMP values than normotensive ones. A similar positive correlation between blood pressure and CSF aAMP concentrations was found also in subarachnoid hemorrhage and syncope groups. On the basis of the present results it is suggested that in cerebrovascular diseases CSF cAMP concentration reflects the size and the time of the destruction of cerebral cells, and correlates with hypertension of the patient possibly indicating an increased sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 174915     DOI: 10.1159/000114735

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  2 in total

1.  Decreased cerebrospinal fluid cyclic adenosine 3',5'-monophosphate in bacterial meningitis.

Authors:  S Weitzman; L B Palmer; S A Berger
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

2.  Cyclic adenosine 3',5' monophosphate in cerebrospinal fluid of multiple sclerosis patients.

Authors:  E Maida; W Kristoferitsch
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.